2021
DOI: 10.4239/wjd.v12.i6.780
|View full text |Cite
|
Sign up to set email alerts
|

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare

Abstract: The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for telemedicine impl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The digitalization of healthcare has evolved over many years, from telemedicine and remote patient engagement to new digital approaches for diagnostics and information exchange. Already rising before the pandemic [1] , [2] , the COVID-19 outbreak in early 2020 accelerated the widespread adoption of virtual healthcare [3] , [4] , [5] .…”
Section: Introductionmentioning
confidence: 99%
“…The digitalization of healthcare has evolved over many years, from telemedicine and remote patient engagement to new digital approaches for diagnostics and information exchange. Already rising before the pandemic [1] , [2] , the COVID-19 outbreak in early 2020 accelerated the widespread adoption of virtual healthcare [3] , [4] , [5] .…”
Section: Introductionmentioning
confidence: 99%